Neurocrine Biosciences, Inc.
3 drugs in NADAC|0 Generic,3 Brand
Neurocrine Biosciences, Inc. lists 3 NDCs in the CMS NADAC file (0 generic, 3 brand), at an average NADAC of $275.20 per unit. The firm's full portfolio, pricing trend are listed below.
Total Drugs
3
0G / 3B
Avg Price / Unit
$275.1966
$258.94 – $283.32
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
of 3 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Frequently Asked Questions
How many drugs does Neurocrine Biosciences, Inc. make?
Neurocrine Biosciences, Inc. lists 3 NDCs in the CMS NADAC file — 0 generic and 3 brand products.
What is the average price of Neurocrine Biosciences, Inc. drugs?
The average NADAC across Neurocrine Biosciences, Inc.'s portfolio is $275.1966 per unit, ranging from $258.9417 to $283.3240.
What types of drugs does Neurocrine Biosciences, Inc. make?
Neurocrine Biosciences, Inc. makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Vesicular Monoamine Transporter 2 Inhibitor (3).
Has Neurocrine Biosciences, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Neurocrine Biosciences, Inc. in the openFDA feed.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
INGREZZA 60 MG CAPSULE Valbenazine | $283.3240 per EA | — |
INGREZZA 80 MG CAPSULE Valbenazine | $283.3240 per EA | — |
INGREZZA 40 MG CAPSULE Valbenazine | $258.9417 per EA | — |